FULGENT GENETICS, INC. Purchase Obligation
FULGENT GENETICS, INC. (FLGT) had Purchase Obligation of $40.60 million as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:PurchaseObligation · last filed 2025-02-28
- 2024-12-31: Purchase Obligation $40.60M.
- 2024-09-30: Purchase Obligation $42.10M.
- 2024-06-30: Purchase Obligation $45.70M.
- 2024-03-31: Purchase Obligation $57.90M.
| Period end | Purchase Obligation |
|---|---|
| 2024-12-31 | $40.60M 10-K · filed 2025-02-28 |
| 2024-09-30 | $42.10M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $45.70M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $57.90M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $51.90M 10-K · filed 2024-02-28 |
| 2023-09-30 | $51.10M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $59.50M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $17.80M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $10.10M 10-K · filed 2023-02-28 |
| 2022-09-30 | $15.80M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $22.80M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $9.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $11.60M 10-K · filed 2022-02-28 |
| 2021-09-30 | $13.80M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $7.60M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $25.40M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $27.60M 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |